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Abstract 
Purpose:  The purpose of this practice inquiry project was to evaluate provider adherence to 
depression screening documentation in the ambulatory electronic health record (AEHR) before 
and after changing locations of the depression screening questions within the AEHR.  Provider 
knowledge about depression screening and barriers related to depression screening were also 
examined. 
Methods:  A retrospective chart review was completed for patients seen for an annual exam by a 
physician provider in a women’s primary care clinic.  Data collected included demographic data, 
co-morbid conditions, depression screen documentation (PHQ-2 & PHQ-9), and interventions 
documented.  A questionnaire was sent to providers in the primary care clinic to assess 
knowledge about depression and identification of barriers related to depressions screening. 
Results:  The retrospective chart review indicated that 2% of the patients were screened for 
depression before the screening tool was moved in the AEHR, and 78% were screened after the 
screening tool was moved.  There were no significant differences in the two population samples.  
Only one patient out of 50 was screened before the screening tool was moved, but 13 patients 
were given prescriptions for medications for the treatment of depression.  Provider knowledge of 
the location of the screening tool has increased. Furthermore, time was identified as the greatest 
barrier to screening for depression. 
Conclusion:  Depression screening improved after changing the AEHR placement of the 
depression screening questions in the areas in which providers document prevention.  “Yes” 
responses from the patient on the PHQ-2 indicated a positive screen for depression, and these 
positive responses on the PHQ-2 automatically directed the provider to the PHQ-9, a more 
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extensive instrument for depression that measures symptom severity.  Time was the most 
significant barrier to screening for depression.  Primary care providers may be the only 
healthcare professional that are able to screen for depression since these providers are most 
easily accessible to patients.  Treating depression helps improve overall health, but can also 
impact the management of other chronic diseases as well. 
  
3 
 
Assessment of Depression Screening in Women’s Primary Care Clinic 
The Centers for Disease Control and Prevention (CDC) (2011) report approximately 
9.1% of the population currently meet the criteria for a diagnosis of depression.  About two-
thirds of these people do not receive the help that they need (National Alliance on Mental Illness 
[NAMI], 2009).  In Kentucky, it is estimated that 22.2% of adults have suffered from major 
depression at some time in their lives, and about 7.6% of Kentucky adults have suffered from 
depression in the last 30 days (Kentucky Cabinet for Health and Family Services, 2004).  
Depression can affect anyone at any age, but women are 70% more likely to experience 
depression in their lifetime than men (National Institute of Mental Health [NIMH], 2014).  It is 
estimated that approximately one in eight women experience depression at some time during 
their lifespan (NAMI, 2009).  Women are more likely than men to have seasonal affective 
disorder, have atypical symptoms of depression, to have comorbid anxiety disorders, and to 
attempt suicide (Gorman, 2006). 
Background 
Depression is a mental illness that can be extremely debilitating and costly for individuals 
(CDC, 2011).  Symptoms associated with depression include: “sadness, anhedonia, pessimism, 
feeling of emptiness, irritability, anxiety, worthlessness, thoughts of death or suicidal ideation, 
disturbed sleep, change in appetite or weight, psychomotor changes, decreased energy, fatigue, 
bodily aches and pains, impaired concentration, indecisiveness, and poor memory” (Chisholm-
Burns et al., 2013, p. 679).   Depression can be attributed to a combination of genetic, biological, 
environmental, and psychological factors, and it affects the individual’s ability to work, sleep, 
study, eat, and enjoy life (NIMH, 2014).  This mental illness is the leading cause of disability for 
adults ages 15-44 in the United States (World Health Organization, 2008).  Depression can cause 
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adults to experience “increased work absenteeism, short-term disability, and decreased 
productivity” (CDC, 2011, p. 1).  Approximately 80% of adults with depression state they have 
some impairment in daily functioning because of their depression, and about 27% state that they 
experience serious difficulties at work as well as at home (Pratt & Brody, 2008).  It is estimated 
that depression causes 200 million lost workdays each year which in turn costs employers $17 to 
$44 billion (Leopold, 2001; Stewart, Ricci, Chee, Hahn, & Morganstein, 2003).  Approximately 
60% of the depressed patients are seen by primary care providers and these providers prescribe 
79% of the total number of anti-depressant medications prescribed (Barkil-Oteo, 2013; Frank, 
Huskamp, & Pincus, 2003).  Therefore, screening in primary care is extremely important. 
If depression is left untreated, it can lead to suicide (NIMH, 2014).  In 2010, the suicide 
rate for the United States was 12.43 per 100,000, while Kentucky’s rate was 14.2 per 100,000 
(Suicide Prevention Resource Center, 2012).  It is estimated that each day there are 42 attempted 
suicides in Kentucky and two deaths from suicide (Suicide Prevention Resource Center, 2012). 
Untreated depression associated with another chronic disease often produces worse 
outcomes.  Katon (2011) stated that “comorbid depression is associated with increased medical 
symptom burden, functional impairment, medical costs, poor adherence to self-care regimens, 
and increased risk of morbidity and mortality in patients with chronic medical disorders” (Katon, 
2011, p. 1).  People with a chronic medical condition, as well as depression, usually have more 
severe symptoms of both conditions (NIMH, 2014).  These individuals have more problems 
adapting to medical conditions, and often incur higher costs associated with treatment when there 
is a co-morbid diagnosis of depression (NIMH, 2014).  Co-morbid conditions often associated 
with depression include diabetes, coronary artery disease, stroke, cancer, chronic pain, thyroid 
disorders, history of depression, and other mood or anxiety disorders (Mitchell et al., 2013).  
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There are extremely high rates of depression associated with the co-morbid diagnoses of 
coronary heart disease and diabetes (Katon, 2011).  Depression can interfere with the patient’s 
ability to engage in self-care of the chronic illness because it has an adverse effect on memory, 
energy, and executive function (Katon, 2011).  For these reasons, treating depression can 
improve the treatment of other co-morbidities as patients may be more likely to adhere to the 
treatment regimen (Whooley, 2012; Richardson & Puskar, 2012).   
Screening for depression is important since the consequences can be irreversible such as 
suicide and worsening of an individual’s health in relation to co-morbid conditions.  The U.S. 
Preventive Task Force Services (USPTFS) recommends that all adults, including pregnant and 
postpartum women should be screened for depression (USPTFS, 2016).  In accordance with this 
recommendation, Healthy People 2020 has set a goal to increase the number of patients who are 
screened for depression by primary care providers from 2.2% in 2007 to 2.4% by 2020 
(USDHHS, 2012). 
Few studies have been conducted to examine provider screening rates for depression in 
primary care.  It is extremely important to implement a systematic strategy for depression 
screening to ensure the completion of screening (Klein, Ciotoli, & Chung, 2011).  The Institute 
for Clinical Systems Improvement’s (ICSI) guideline for depression in primary care recommends 
first using the PHQ-2 instrument; in the event of a positive score (3 or greater), the PHQ-9 
instrument should then be completed (Kroenke, Spitzer, & Williams, 2003; Mitchell et al., 
2013).  Use of the PHQ-9 instrument is recommended in the primary care setting because it is 
useful in indicating the severity of depression (Spritzer, Kroenke, & Williams, 1999). 
In addition to screening, the providers must understand the risk factors associated with 
depression to aid in understanding which patients may be at greater risk of developing depression 
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(Mitchell et al., 2013).  Some risk factors associated with depression are frequent visits to 
primary care providers, patients with unexplained somatic complaints, history of depression, 
family history of depression, chronic health conditions, other mental health disorders, and 
refugee or immigrant status (Baas et al., 2009; Christensen, Sokolowski, & Olesen, 2011; 
Maradiegue & Khan, 2013; Romera et al., 2013). 
The healthcare system is changing as Medicare and Medicaid have instituted a Physician 
Quality Reporting System (PQRS) (Koltov & Damle, 2014).  This system is an incentive and 
penalty program in which providers will no longer be paid a fee for their service, but rather paid 
based on the quality of care delivered (Koltov & Damle, 2014).  In the near future, the Centers 
for Medicare and Medicaid Services (CMS) will begin to base reimbursements on these quality 
indicators (CMS, 2013).  One of the indicators is screening for clinical depression and 
developing a follow-up plan (Measure # 134, NQF 0148) (CMS, 2013).   
Providers may feel overwhelmed and have difficulty remembering all screenings that 
must be completed.  However, electronic health record provider prompts have been shown to 
significantly increase screening for health conditions (Hsu et al., 2013; Van Cleave et al., 2012).   
Devising a systematic way of screening and a protocol to follow is useful for implementing 
screening and providing ease to providers who feel they are not sufficiently educated about 
depression (Klein et al., 2011).   Van Cleave et al. (2012) performed a systematic review 
examining interventions to improve screening processes and follow up.  Some of these studies 
included electronic medical record templates and reminders which helped prompt providers to 
screen.  These electronic medical record enhancements as an intervention greatly improved 
screening rates from baseline (Van Cleave et al., 2012). 
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In the ambulatory electronic health record (AEHR) in a primary care clinic in a university 
setting, depression screening was embedded in a category listed only as screening with a 
checkbox to indicate completed.  The depression screening questions were embedded in a detail 
button which needed to be opened in order to complete the PHQ-2 questions.  The full PHQ-9 
screening tool was not available. CMS states that the PHQ questions must be answered 
individually in order to meet the criteria for documentation of the quality indicator for 
depression. The clinic manager, along with the informaticist, made the decision to move the two 
questions of the PHQ-2 directly into the prevention area from the screening section of the AEHR 
in January 2015 to better meet CMS requirements.  The two PHQ-2 questions can be answered 
with a check box, yes or no, and the full PHQ-9 questions are available when clicking on the 
radio button.  There is a text box to indicate the PHQ-9 score and further evaluation. 
Purpose 
 The purpose of this Quality Improvement (QI) project was to evaluate depression 
screening rates in a women’s primary care clinic by assessing documentation in the ambulatory 
electronic health record (AEHR).  The primary aim was to assess provider adherence to 
depression screening during annual exams before and after the depression screening tool location 
was changed in the AEHR.  Before January 2015, the PHQ-2 screening tool was difficult to find 
as it was embedded in the screening section in the annual exam form template in the AEHR and 
required multiple steps in order to gain access to this screening tool.  As of January 2015, the 
PHQ-2 was moved to the prevention section of the AEHR and was more visible to providers.  
The two PHQ-2 questions are part of the prevention section with the PHQ-9 questions under a 
radial dial.  The changes in location in the AEHR was discussed at a faculty meeting as well as 
the CMS requirements for depression screening.   
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This QI project was a retrospective medical record review completed to compare the rates 
of depression screening completed by providers before and after moving the depression 
screening tool in the AEHR.  The secondary aim of this study was to assess provider knowledge 
as well as barriers to completing depression screening.  This was completed through the use of 
an e-mail survey sent to the providers. 
Methods 
Design 
 A retrospective medical record review was completed in March 2016 to assess 
documentation of depression screening during annual exams as well as interventions 
recommended for depression by the PHQ-9 depression screening tool.  Fifty records were 
randomly selected for review during the four months before the PHQ screening tool was moved 
(September 2014-December 2014) and 50 records were randomly selected for review during the 
four months after the PHQ screening tool was relocated to the preventions section of the AEHR 
(March 2015-June 2015).  In addition, a provider survey was sent via e-mail to participating 
providers to assess their knowledge of depression screening and the barriers to screening 
patients. 
Human Subject and Research Approval Procedures 
 Permission to conduct this QI project was granted by the University of Kentucky 
Institutional Review Board (IRB).  Patient consent was waived in compliance with IRB 
regulations since data collection was completed through a retrospective medical record review in 
which patient identifiers were not collected.  Consent for the survey was implied by providers 
completing the survey with all responses being confidential. 
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Study Population 
 This QI project was completed in a women’s health clinic within a university setting.  A 
total of 100 charts were randomly selected, 50 from the four months (September 2014-December 
2014) before the depression screening instrument was moved and 50 from the four months 
(February 2015-June 2015) after the instrument was relocated to the prevention section of the 
AEHR.  The inclusion criteria included female patients ages 18-89 who presented for an annual 
physical exam in the clinic.  Participating providers for the survey portion of the study included 
the four physician providers at the clinic.  
Data Collection 
 The Center for Clinical and Translational Science (CCTS) at the University of Kentucky 
(UK) assembled a list of medical record numbers, patient names, physician provider, 
appointment types of WELL40 or EP40, and appointment dates of patients that were seen 
between September 2014 and December 2014 as well as between March 2015 and June 2015.  A 
list of 145 charts before moving the PHQ-2 and 185 charts after moving the PHQ-2 location 
were obtained for the study.  The charts were selected using a random number generator for each 
of the two samplings of patients, 50 from before moving the PHQ-2 and 50 from after moving 
the PHQ-2.  Each of the selected charts were given an identification number that would be used 
for collecting data during the medical record review to ensure no identifying information would 
be collected on the patients. 
 Depression screening charted in the provider note was assessed for documentation of the 
PHQ-2 being documented and the PHQ-9 being performed if the PHQ-2 was positive according 
to the National Institute of Health and Clinical Excellence (NICE) guideline.  The NICE 
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guideline (2009) recommends that patients should be asked the following two questions (PHQ-2) 
in order to screen for depression: 
1. During the last month, have you often been bothered by feeling down, depressed, or 
hopeless? 
2. During the last month, have you often been bothered by having little interest or 
pleasure in doing things? (p. 16) 
Patients who answer ‘yes’ to either of these questions, should then be asked all the questions on 
the PHQ-9 depression screening instrument to assess the risk and severity of depression (NICE, 
2009).  In addition to gathering this information, age, race, marital status, employment status, 
insurance coverage, and common co-morbidities associated with a high risk of depression were 
collected.  Interventions such as no intervention, medication prescription, referral, and other 
recommendations were also collected in this study. 
 All medical records were accessed in the clinic director’s secure clinic office on a 
computer that was encrypted and password protected.  The data collected for the medical record 
review was documented and stored in REDCap, a secure online data collection tool provided by 
the University of Kentucky.  The data are securely hosted on Biomedical Informatics servers in 
the secure data center operated by the Institute for Pharmaceutical Outcomes and Policy. 
The provider survey was disseminated via REDCap in February 2016 and the four 
providers were given three weeks to respond.  All completed surveys were stored using 
REDCap.  The survey assessed provider’s knowledge about the location of the PHQ-2 in the 
AEHR, screening practices, knowledge of the screening tool, and barriers to screening.  The 
management of depression, if it was diagnosed, was also evaluated. 
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Data Analysis 
 Results from the retrospective medical record review were analyzed using the Statistical 
Package for the Social sciences (SPSS) software.  Descriptive statistics using frequencies were 
used to assess age, race, employment status, marital status, insurance coverage, co-morbidities, 
and the number of patients that were screened using the PHQ-2 tool.  In addition, a chi-square 
test of association and an independent samples t-test were used to ensure that the pre- and post- 
population samples were not significantly different.  A chi-square test was run in order to 
compare the proportion of records with depression screening documentation before and after 
movement of the instrument to the prevention section of the AEHR.  In order to determine 
whether patient demographics such as age, race, marital status, employment status, type of 
insurance, and co-morbid conditions were associated with whether a provider would screen for 
depression, a chi-square test was also completed.  Results were considered statistically 
significant if the p-value was < 0.05.  The survey results were descriptively evaluated by the 
primary investigator since only three surveys were completed. 
Results 
Retrospective Ambulatory Electronic Health Record Review 
 The age range for the 100 charts reviewed was ages 19-76, with a mean of 44.38 (Table 
1).  Caucasian women made up 88% of the study sample while 11% were African American 
women, and 1% were Asian women.  Due to the numbers associated with different races, it was 
recoded to state that Caucasians made up 88% of the sample and 12% were other races.   Sixty-
one percent of the study sample was married, 28% was single, and 11% were divorced.  The 
employment status of the sample consisted of 9% working part-time, 73% working full-time, 
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16% not employed, and 2% did not have employment status documented.  Insurance coverage 
for the sample included 80% having HMO or PPO insurance, 11% having Medicaid insurance, 
8% having Medicare insurance, and 1% not having insurance documented (Table 2).   
There are many co-morbid conditions that can be associated with depression.  The study 
population consisted of 4% of the women diagnosed with diabetes, 2% had coronary artery 
disease, 2% had a current diagnosis of cancer, while 6% had a history of cancer, 12% had 
chronic pain, 30% had a history of depression, 26% had a thyroid disorder, and 19% had other 
mood or anxiety disorders (Table 2). 
 The samples were examined overall, as well as individually, according to before and after 
the relocation of the PHQ-2 and after the movement of the PHQ-2.  When examining the 
samples pre- and post-relocation, there was no significant difference between the two samples as 
all p-values for age, race, marital status, employment status, insurance, and co-morbid conditions 
were > 0.05 (Table 1 and Table 2). 
 Only 2% of the sample was screened for depression during the time period September 
2014-December 2014 before the PHQ-2 screening tool was moved.  From March 2015-June 
2015, after the screening tool was moved, 78% of the patients were screened for depression 
during their annual exam (Figure 1).  This difference was significant when running Pearson’s 
chi-square test of association as the p-value was <0.001 (Table 4). 
 Only one patient of the 40 patients screened answered yes to the PHQ-2 questions.  The 
PHQ-9 was documented for that patient.  If the PHQ-2 is negative, then there is no reason to 
complete the PHQ-9. 
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 When determining whether patient demographics, such as age, race, marital status, 
employment status, insurance and co-morbid conditions, are associated with whether a provider 
would screen for depression or not, there was no association between these factors.  Pearson’s 
chi-square test of association was completed on all the demographics and all p-values were > 
0.05 (Table 5). 
 Interventions assessed when looking at the charts included no intervention, medication 
prescribed, counseling referral, or other intervention not previously listed.  No intervention 
performed occurred 86% of the time overall, 78% of the time before the PHQ-2 tool was moved 
and 94% of the time after the PHQ-2 instrument was moved.  Medication was prescribed 13% of 
the time overall, 20% of the time before the PHQ-2 tool was moved and 6% of the time after the 
tool was moved.  Counseling referral and other interventions only occurred once overall, during 
the time before the PHQ-2 was moved (Table 6). 
Provider Survey 
 Three out of four providers completed the survey, a 75% response rate.  All of the 
responses to the survey are summarized in Table 3.  Of those who responded, only 1 stated that 
she knew where the PHQ-2 depression screening instrument was located in the AEHR before it 
was moved in January of 2015.  All of the providers stated that they had at times screened for 
depression and did not document the result before the screening tool was moved.   
 The three providers that responded all indicated that they knew the location of the 
depression screening instrument in the prevention section after the relocation in January 2015.  
Two out of the three providers stated that they continue to screen without documenting the 
results.  Two of the providers also stated that moving the screening tool has helped improve 
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depression screening adherence.  Only two out of the three providers indicated that if their 
patient had a history of depression and the patient is there for follow-up, they use the PHQ-
2/PHQ-9 to see if the patient is improving with the treatment prescribed. 
 The only barrier that was reported related to screening for depression was time, and this 
was the response of two of the providers.  All three providers indicated that if the PHQ-2 score 
was 2 or above, they were supposed to complete the PHQ-9.  All three providers also specified 
that they were aware that screening for depression is a PQRS measure and could soon involve 
monetary penalties if it is not completed. 
 The treatment plan for a patient could involve different modalities.  Three providers 
indicate that they use medications, while none of the providers use hospitalization in their 
treatment plan.  All three providers use referral, and two of the providers include a wait and 
reassess intervention.  One provider indicated that she seeks immediate attention if there is 
suicide ideation or homicide ideation present. 
Discussion 
 Screening for depression is essential in diagnosing a patient and adequately treating this 
mental disorder.  Primary care providers are the most accessible to patients and should be 
responsible for depression screening as many patients seek help from their primary care provider 
for mental health issues because of the trust that they have in this provider (Zeidenstein, 2004). 
Provider depression screening rates are not well-documented in the literature.  However, 
barriers related to depression screening consistently include time constraints (Baas et al., 2009; 
Maradiegue & Khan, 2013; Romera et al., 2013).  This QI project is consistent with reported 
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barriers to screening as two-thirds of the providers stated that time was a barrier encountered in 
relation to depression screening.   
The medical chart review indicated that 2% of the patients were screened for depression 
before the screening questions were moved, which is less than the initial screening rate of 2.2% 
according to the Healthy People 2020 (USDHHS, 2012).  However, after the screening tool was 
moved, the screening rate increased to 78%, which surpasses the Healthy People 2020 goal of 
primary care providers screening for depression 2.4% of the time (USDHHS, 2012). 
There is a lack of documentation in relation to depression screening (Romera et al., 
2013).  This was supported by this QI project as providers stated that there are times they did 
screen and did not document the PHQ-2 score. 
One patient was screened for depression before the screening tool was moved.  This 
patient’s appointment was on December 8, 2014.  The screening tool was moved on January 28, 
2015, just a month later.  During this time, the providers were receiving training regarding the 
depression screen being moved and for this reason, it may have been fresh in their minds.  For 
this reason, it is possible that the training influenced the provider and caused this one patient to 
be screened for depression when no others were screened before the instrument was moved in 
the AEHR. 
There was only one patient that screened positive for depression out of the 100 patient 
charts reviewed.  This number is less than the national average of 9.1% of people having 
depression (CDC, 2011).  This could be attributed to the sample seen at this particular clinic.  
Most of the people in this clinic are employed and have PPO insurance through the university.  
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Results from the study also indicated that providers were prescribing medications without 
documented depression screening patients especially before the screening tool was moved.  Only 
one patient was screened during this period, but 13 patients received a prescription for a 
medication that treats depression.  The PHQ-9 could have been completed and documented to 
evaluate whether or not medication changes were needed as recommended by ICSI (Mitchell et 
al., 2013).  Otherwise, there were no data to show why a patient is receiving that medication.  In 
the patients’ notes, the providers simply stated that the patient had depression and wrote the 
prescription.  There was no explanation of the patient doing well on the medication or reasons 
for medication changes. 
This study indicated that moving the depression screening instrument greatly increased 
the rates of screening.  Screening tools must be accessible to providers and easy to use.  These 
findings agree with previous studies where provider prompts in the EHR were shown to 
significantly increase screening rates for different health conditions (Hsu et al., 2013; Van 
Cleave et al., 2012).  This allows providers to have reminders during busy and stressful clinic 
settings. 
Through completion of this study, some of the aspects included in the essentials of 
doctoral education for advanced nursing practice were achieved.  The first essential is Scientific 
Underpinnings for Practice.  This particular essential was met as this project used “science-
based theories and concepts to describe actions and advanced strategies to enhance, alleviate, and 
ameliorate health and health care delivery” as well as evaluating the outcomes (AACN, 2006, p. 
9).  The second essential is Organizational and Systems Leadership for Quality Improvement and 
Systems Thinking.  Essential two was met through this project as the primary investigator saw a 
problem in the health care delivery system and worked to “promote patient safety and excellence 
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in practice” (AACN, 2006, p. 10).  In addition, care delivery approaches were developed and 
evaluated in order to meet the needs of the population while “ensur[ing] accountability for 
quality of health care and patient safety for the population” (AACN, 2006, p. 10).   The eighth 
and final doctoral of nursing practice essential is Advanced Nursing Practice.  This essential 
includes that the professional will “design, implement, and evaluate therapeutic interventions 
based on nursing science and other sciences.” (AACN, 2006, p. 16).  This was completed 
through this project as a new intervention for depression screening was designed, implemented, 
and evaluated in order to improve depression screening in the clinic. 
Limitations 
 One limitation of this study is the small sample size for both the medical record review as 
well as the provider survey.  However, despite the small sample size, documentation of 
depression screening was significant when comparing documentation before and after moving 
the location of the depression screening questions in the AEHR.  The provider survey only had 
three responses out of the four providers, and while this is a 75 percent response rate, it still is a 
small sample size making it difficult to generalize findings to other clinical settings. 
 Another identifiable limitation is that the patient sample seen at this university setting is 
unique.  Many of the patients work at the university which could possibly skew the results 
regarding the patient sample and diagnosis of depression.  This particular sample population was 
not diverse due to many patients being associated with the university and having university 
insurance.  Therefore, the results of this study may not be generalizable to other populations. 
 An additional limitation is that documentation of depression screening is completed by 
providers who may have time constraints.  For this reason, it could be that providers could have 
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asked the PHQ-2 questions, but failed to document that they completed this screen.  More 
research is needed in relation to depression screening and screening rates in primary care clinics.   
Implications for Practice 
 Interventions to encourage easy access for documentation can improve documentation of 
depression screening as well as for other disease processes.  Provider education related to 
screening and monetary reimbursement-related expectations can also improve the documentation 
of screening rates. 
 Screening allows providers to assess if a patient is depressed as well as the patient’s level 
of depression. This determines whether treatment should be initiated or changed if a depression 
diagnosis has previously been documented and are not at goal (NICE, 2009).  The process is 
quick, as initially the PHQ-2 consists of two yes or no questions.  If the answer is yes to both 
questions asked, then the provider can perform the PHQ-9 and get a comprehensive score that 
indicates the severity of depression to aid in creating a treatment plan (Kroenke, Spitzer, & 
Williams, 2003; Mitchell et al., 2013). 
 Screening for depression is especially important for patients with certain co-morbid 
diseases as they frequently suffer from depression.  These co-morbid conditions include diabetes, 
coronary artery disease, stroke, cancer, chronic pain, thyroid disorders, history of depression, and 
other mood or anxiety disorders (Mitchell et al., 2013). 
 Once a patient is diagnosed with depression, the PHQ-9 can be used to determine if the 
prescribed treatment is effective and to indicate whether or not changes need to be made, such as 
medication adjustments or referral for counseling (Mitchell et al., 2013).  If a provider is going to 
renew a prescription for medications to treat depression, the PHQ-9 should be completed in order 
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to provide information concerning the level of depression and guide the provider on continuing 
the current dose or making changes to the dose.  The importance of follow-up is extremely 
important as the goal is to alleviate the symptoms the patient is experiencing, and if the patient 
has a co-morbidity, the treatment of depression also helps improve the management of the other 
disease (Mitchell et al., 2013; Richardson & Puskar, 2012; Whooley, 2012).  Follow-up can 
therefore help the patient in the many aspects of treating their medical conditions and improve 
their overall health as a person.  Documentation of the patient’s state of depression and response 
to treatment is important for overall management.  Treatment of depression also has a positive 
impact on other serious health problems.  Therefore, completion of the PHQ-9 is extremely 
important in the management and treatment of a patient with depression. 
Conclusion 
 Primary care providers are at the forefront in recognizing and treating depression.  These 
providers are in the optimal position to screen for and treat depression because many patients 
prefer to remain in primary care because of the familiarity, location, patient-clinician 
relationship, convenience, and reduced stigma related to diagnosis of a mental health illness 
(Zeidenstein, 2004).  If this disease process is not diagnosed in this setting, a patient may never 
receive treatment.  Therefore, it is imperative that primary care providers screen for depression.  
This screening process may help in the treatment of many conditions because if depression is 
found, it is possible that it is hindering the patient from adequately following the health plan for 
other medical conditions.  In this QI project, electronic prompts in the AEHR improved the 
provider screening rates for depression by 76%.  By providing reminders or increasing the ease 
of documentation for clinicians, screening rates will increase allowing patients to receive the 
treatment they need to improve their mental and overall health. 
20 
 
Table 1. Population Sample Comparison of Continuous Variables  
 Overall Sample 
(n=100) 
Pre- movement 
of PHQ-2 
(n=50) 
Post- movement 
of PHQ-2  
(n=50) 
 
p-value 
Age Range 19-76 19-76 22-65  
0.593 Age Mean 44.38 44.32 44.44 
Standard 
Deviation 
12.960 13.604 12.42 
 
Table 2.  Population Sample Comparison of Categorical Variables 
 Overall 
Sample 
(n=100) 
Pre- movement 
of PHQ-2 
(n=50) 
Post- movement 
of PHQ-2  
(n=50) 
p-
value 
Race 
     White 
     Other 
 
88 
12 
 
47 
3 
 
41 
9 
 
0.065 
Marital Status 
     Single 
     Married 
     Divorced 
 
28 
61 
11 
 
13 
30 
7 
 
15 
31 
4 
 
0.613 
Employment Status 
     Part-Time 
     Full-Time 
     Not Employed 
     Not Documented 
 
9 
73 
16 
2  
 
6 
36 
7 
1 
 
3 
37 
9 
1 
 
 
0.626 
Insurance 
     HMO or PPO 
     Medicaid 
     Medicare 
     Not Documented 
 
80 
11 
8 
1 
 
39 
5 
5 
1 
 
41 
6 
3 
0 
 
 
0.809 
Co-morbid Conditions 
     Diabetes 
     CAD 
     Stroke 
     Cancer 
     History of Cancer 
     Chronic Pain 
     History of Depression 
     Thyroid Disorder 
     Other Mood or Anxiety Disorder 
 
4 
2 
0 
2 
6 
12 
30 
26 
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3 
0 
0 
1 
3 
6 
17 
16 
12 
 
1 
2 
0 
1 
3 
6 
13 
10 
7 
 
0.307 
0.153 
n/a 
1.000 
1.000 
1.000 
0.383 
0.171 
0.202 
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Table 3. Provider Survey Responses 
Question Response N (out of 3) 
Did you know where the PHQ-
2 depressions screening 
instrument was located in the 
AEHR before it was moved on 
January 28, 2015? 
Yes 
No 
1 
2 
Were there times when you 
screened for depression but 
did not document the results 
before January 28, 2015? 
Yes 
No 
3 
0 
Do you currently know where 
the PHQ-2 depression 
screening instrument is 
located? 
Yes 
No 
3 
0 
Do you now sometimes screen 
for depression without 
documenting the score? 
Yes 
No 
2 
1 
Has moving the location of the 
PHQ-2 to the screening section 
helped with your depression 
screening adherence? 
Yes 
No 
2 
1 
If your patient has a history of 
depression and is there for 
follow-up, do you use the 
PHQ-2/PHQ-9 to see if they 
are improving with the 
treatment prescribed? 
Yes 
No 
2 
1 
What are the barriers you 
experience related to 
screening for depression? 
Time 
None 
2 
1 
At what score with the PHQ-2 
are you supposed to complete 
a PHQ-9? 
≥ 2 
≥ 3 
≥ 4 
3 
0 
0 
Are you aware that screening 
for depression is a PQRS 
measure and could soon 
involve monetary penalties if it 
is not completed? 
Yes 
No 
3 
0 
What do you include in your 
treatment plan when you 
diagnose a patient with 
depression?  Please check all 
that apply. 
Medications 
Hospitalization 
Referral 
Wait and Reassess 
Seek immediate attention if SI/HI 
3 
0 
3 
2 
1 
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Table 4. Comparison of Screening before and after moving PHQ-2 
 Overall Sample 
(n=100) 
Pre- movement 
of PHQ-2 
(n=50) 
Post- movement 
of PHQ-2  
(n=50) 
 
p-value 
Depression 
Screening 
40 1 39 <0.001 
  
Table 5. Association Between Patient Demographics and Provider Screening 
Patient Demographics p-value 
Age 0.382 
Race 0.384 
Marital Status 0.413 
Employment Status 0.442 
Type of Insurance 0.075 
Diabetes Co-morbidity 0.648 
CAD Co-morbidity 1.000 
Stroke Co-morbidity n/a 
Cancer Co-morbidity 1.000 
History of Cancer Co-morbidity 0.397 
Chronic Pain Co-morbidity 0.758 
Previous Diagnosis of Depression Co-morbidity 0.656 
Thyroid Disorder Co-morbidity 0.114 
Other Mood or Anxiety Disorder Co-morbidity 0.176 
 
Table 6.  Treatment Plan Interventions 
 Overall Sample 
n=100 
Pre- movement of 
PHQ-2 (n=50) 
Post- movement of 
PHQ-2 (n=50) 
None 86 39 47 
Medication 13 10 3 
Counseling Referral 1 1 0 
Other 1 1 0 
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Figure 1.  Depression Screening Rates Before and After Moving the PHQ-2 instrument 
 
 
Figure 2. Treatment Plan Interventions Before and After Moving the PHQ-2 Instrument 
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